PremiumThe FlyAlumis price target lowered to $25 from $26 at Oppenheimer Acelyrin stockholders approve merger agreement with Alumis Alumis stockholders approve merger agreement with Acelyrin PremiumThe FlyAcelyrin adopts limited-duration stockholder rights plan Acelyrin says Concentra indication not expected to result in superior proposal Acelyrin, Alumis reaffirm strategic, financial rationale of proposed merger PremiumThe FlyAcelyrin Inc trading resumes Alumis, Acelyrin to merge in all-stock transaction Acelyrin Inc trading halted, news pending 
